Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 101,622 | 2,294 | 1,991 | 345 | 455 |
| Operating Income | 1,072 | -2,294 | -1,991 | -345 | -455 |
| Other Income | -19,138 | -2,487 | 818 | 1,729 | 1,384 |
| Pre-tax Income | -18,066 | -4,780 | -1,173 | 1,385 | 930 |
| Net Income Continuous | -18,066 | -4,780 | -1,173 | 1,385 | 930 |
| Net Income | $-18,066 | $-4,780 | $-1,173 | $1,385 | $930 |
| EPS Basic Total Ops | -0.93 | -0.27 | -0.07 | 0.08 | 0.05 |
| EPS Basic Continuous Ops | 0.13 | -1.39 | -0.34 | 0.40 | 0.27 |
| EPS Diluted Total Ops | -0.93 | -0.27 | -0.07 | 0.08 | 0.05 |
| EPS Diluted Continuous Ops | 0.13 | -1.39 | -0.34 | 0.40 | 0.27 |
| EBITDA(a) | $-101,622 | $-2,294 | $-1,991 | $-345 | $-455 |